Work Here?
Deepcell specializes in biotechnology focused on cell analysis and sorting. Its main product, the REM-I platform, utilizes label-free imaging, deep learning, and gentle sorting to analyze and categorize cells based on their shape and structure. This technology provides a high-dimensional quantitative readout, offering detailed data about individual cells. The REM-I platform employs advanced microfluidics to manipulate tiny fluid droplets and artificial intelligence to interpret the imaging data. This allows for in-depth characterization of cells, which is valuable for researchers in scientific and medical fields, such as pharmaceutical companies and academic institutions studying diseases. Deepcell's business model includes selling or licensing the REM-I platform and offering data analytics services to clients, making it a leader in cell analysis technology.
Company Stage
Series B
Employees
51-200
Industries
AI & Machine Learning, Biotechnology
Total Funding
$98M
Headquarters
N/A
Founded
2015
Find jobs on Simplify and start your career today